果冻影院

header-logo
GettyImages-609179959-hero
headshot

Bronwen E Shaw, MD, PhD

Professor; Scientific Director CIBMTR

view physician profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine
  • PhD

Biography

Dr. Shaw received her MD (MBChB) from the University of Cape Town, South Africa in 1993. All of her subsequent postgraduate haematology specialist training was completed in London, UK where she also received her PhD in Clinical Sciences and Immunology from University College London in 2004. Her PhD was entitled Understanding the immunogenetic and clinical factors which influence the outcome of haematopoietic stem cell transplantation using unrelated donors.

Research Interests

Prior to taking up her position at the CIBMTR and 果冻影院, Dr. Shaw was a Consultant Haematologist specializing in Stem Cell Transplantation and Survivorship issues at the Royal Marsden Hospital in Sutton, UK. She simultaneously held the position of Chief Medical Officer at Anthony Nolan, the UK’s national unrelated donor registry. In this position she had oversight of the donor research activities and the medical operations of the organization. She also held a senior scientific role, with direct supervision of several PhD and MD students working in the area of immunogenetics, donor selection, and the donor experience.

Publications

  • (Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S, Leckrone E, Wu J, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis R, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Madbouly A, Maiers M, Fingerson S, Cook R, Ballen K, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Jimenez Jimenez AM.) J Clin Oncol. 2025 Jun 16:JCO2500856 PMID: 40523209 SCOPUS ID: 2-s2.0-105008736226 06/16/2025

  • (Schoettler ML, Gavriilaki E, Carreras E, Cho BK, Dandoy CE, Ho VT, Jodele S, Moiseev I, Sánchez-Ortega I, Srivastava A, Atsuta Y, Carpenter PA, Koreth J, Kröger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda AM, Soiffer R, Vasu S.) Transplant Cell Ther. 2025 Jun 11 PMID: 40514012 06/14/2025

  • (Nath K, Zhang MJ, Bye M, Abid MB, Benjamin C, Betts BC, Bhatt NS, Arrieta-Bolaños E, Bolon YT, Gadalla SM, Grunwald MR, Krem MM, Lee SJ, Marsh SGE, Martino R, Mehta PA, Milano F, Prestidge T, Saultz JN, Shaw BE, Spellman SR, Choe HK, Shaffer BC.) Blood Adv. 2025 Mar 06 PMID: 40048743 03/06/2025

  • (Shaffer BC, Gooptu M, DeFor T, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez AM, Al Malki MM.) J Clin Oncol. 2025 Feb;43(4):476-478 PMID: 39504503 PMCID: PMC11779590 SCOPUS ID: 2-s2.0-85209770508 11/06/2024

  • (Spellman SR, Sparapani R, Maiers M, Shaw BE, Laud P, Bupp C, He M, Devine SM, Logan BR.) Blood Adv. 2024 Dec 10;8(23):6082-6087 PMID: 39368807 PMCID: PMC11652765 SCOPUS ID: 2-s2.0-85212173730 10/06/2024

  • (Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bolaños-Meade J, Abboud R, Briggs AD, Khimani F, Modi D, Newcomb R, Shpall EJ, Bupp C, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez Jimenez AM, Al Malki MM.) J Clin Oncol. 2024 Oct;42(28):3277-3286 PMID: 39018507 PMCID: PMC11421565 SCOPUS ID: 2-s2.0-85201047010 07/17/2024

  • (Dehn JG, Logan B, Shaw BE, Devine S, Ciurea SO, Horowitz M, He N, Pusic I, Srour SA, Arai S, Juckett M, Uberti J, Hill L, Vasu S, Hogan WJ, Hayes-Lattin B, Westervelt P, Bashey A, Farhadfar N, Grunwald MR, Leifer E, Symons H, Saad A, Vogel J, Erickson C, Buck K, Lee SJ, Pidala J.) medRxiv. 2024 Sep 16 PMID: 39371123 PMCID: PMC11451755 10/07/2024

  • (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE.) Transplant Cell Ther. 2024 Sep;30(9):917.e1-917.e12 PMID: 38944153 PMCID: PMC11587342 SCOPUS ID: 2-s2.0-85199289175 06/30/2024

  • (Schoemans H, Burns LJ, Liptrott SJ, Murray J, Kenyon M, Barata A, Bolaños N, Scholl I, Hamilton B, Phelan R, Buchbinder D, Penack O, Moiseev I, Boreland W, Peczynski C, De Geest S, Sureda A, Snowden JA, Shaw B, Peric Z, Kroeger N.) Bone Marrow Transplant. 2024 Sep;59(9):1286-1294 PMID: 38890544 PMCID: PMC11371514 SCOPUS ID: 2-s2.0-85196315053 06/19/2024

  • (Bolon YT, Atshan R, Allbee-Johnson M, Estrada-Merly N, Auletta JJ, Broglie L, Cusatis R, Page KM, Phelan R, Sajulga R Jr, Shaw BE, Spahn A, Steinert P, Stewart V, Vierra-Green C, Lee SJ, Spellman SR.) Transplant Cell Ther. 2024 Sep;30(9):921.e1-921.e22 PMID: 38871054 PMCID: PMC11809440 SCOPUS ID: 2-s2.0-85198556368 06/14/2024

  • (Schonfeld SJ, Valcarcel B, Meyer CL, Shaw BE, Phelan R, Rizzo JD, Brunson A, Cooley JJP, Abrahão R, Wun T, Gadalla SM, Engels E, Albert PS, Yusuf R, Spellman SR, Curtis RE, Auletta JJ, Muffly L, Keegan THM, Morton LM.) Blood Adv. 2024 Aug 13;8(15):4102-4112 PMID: 38865710 PMCID: PMC11342185 SCOPUS ID: 2-s2.0-85201458048 06/12/2024

  • (Sparapani RA, Maiers M, Spellman SR, Shaw BE, Laud PW, Devine SM, Logan BR.) medRxiv. 2024 May 09 PMID: 38766030 PMCID: PMC11100939 05/20/2024

Publications of from the

© 2025 果冻影院.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 果冻影院 (果冻影院) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 果冻影院 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

果冻影院's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 果冻影院 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.